Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones

2025.12.04 22:08

I'm PortAI, I can summarize articles.

Insulet Corp. (PODD) stock rose 2.72% to $315.92, outperforming competitors in a mixed trading session. The S&P 500 Index rose 0.11%, while the Dow Jones fell 0.07%. Insulet's stock snapped a three-day losing streak and closed 10.98% short of its 52-week high. Trading volume exceeded its 50-day average. Competitors Eli Lilly & Co. fell 1.85%, DexCom Inc. rose 0.62%, and Johnson & Johnson fell 1.39%.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Insulet Corp. (PODD) rose 2.72% to $315.92 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.11% to 6,857.12 and the Dow Jones Industrial Average falling 0.07% to 47,850.94. The stock's rise snapped a three-day losing streak. Insulet Corp. closed 10.98% short of its 52-week high of $354.88, which the company reached on November 20th. The stock outperformed some of its competitors Thursday, as Eli Lilly & Co. (LLY) fell 1.85% to $1,014.49, DexCom Inc. (DXCM) rose 0.62% to $65.25, and Johnson & Johnson (JNJ) fell 1.39% to $202.48. Trading volume (747,412) eclipsed its 50-day average volume of 651,120. Data source: Dow Jones Market Data, FactSet. Data compiled December 4, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 12-04-25 1708ET